Cargando…
Adjuvant therapy for high‐risk cutaneous squamous cell carcinoma: 10‐year review
Standard of care for high‐risk cutaneous squamous cell carcinoma (cSCC) is surgical excision of the primary lesion with clear margins when possible, and additional resection of positive margins when feasible. Even with negative margins, certain high‐risk factors warrant consideration of adjuvant the...
Autores principales: | Newman, Jason G., Hall, Mary A., Kurley, Sarah J., Cook, Robert W., Farberg, Aaron S., Geiger, Jessica L., Koyfman, Shlomo A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453797/ https://www.ncbi.nlm.nih.gov/pubmed/34096664 http://dx.doi.org/10.1002/hed.26767 |
Ejemplares similares
-
Adjuvant radiotherapy in high-risk cutaneous squamous cell cancer of the head and neck in immunosuppressed patients
por: Koyfman, Shlomo A., et al.
Publicado: (2015) -
Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinoma
por: Arron, Sarah T., et al.
Publicado: (2022) -
Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review
por: Farberg, Aaron S., et al.
Publicado: (2022) -
Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients
por: Borman, Sherri, et al.
Publicado: (2022) -
Incorporation of the 40-Gene Expression Profile (40-GEP) Test to Improve Treatment Decisions in High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients: Case Series and Algorithm
por: Singh, Gaurav, et al.
Publicado: (2023)